危重症中的动态左心室流出道梗阻:病因驱动管理与床旁经胸超声心动图的作用
该文报告了在某三级中心管理的三例典型动态左心室流出道梗阻病例:一例66岁男性低血容量所致(峰值压差29 mmHg),液体复苏后逆转;一例71岁女性正性肌力药所致(压差36 mmHg),需β受体阻滞;一例脓毒症休克患者严重梗阻,经液体复苏、镇静和血管加压药优化联合处理。病理生理导向的干预包括低血容量者液体复苏、高动力者镇痛/镇静、脓毒症者去甲肾上腺素提升前负荷和后负荷,系列床旁经胸超声心动图确认压差下降。早期经胸超声心动图导向治疗实现:病例1血管加压药48小时内撤停、病例2血流动力学24小时内稳定、病例3脓毒症休克逆转。作者强调当代ICU几乎所有低血压患者都应接受床旁经胸超声心动图作为标准诊疗。
要点
- 脓毒症休克人群中左心室流出道梗阻的ICU死亡率可达53%,床旁经胸超声心动图对早期识别至关重要。
- 病例1:66岁男性低血容量所致梗阻(峰值压差29 mmHg),液体复苏后逆转,48小时内撤停血管加压药。
- 病例2:71岁女性正性肌力药所致梗阻(压差36 mmHg),需β受体阻滞,24小时内血流动力学稳定。
- 病例3:脓毒症休克合并严重梗阻,经液体复苏、镇静和血管加压药优化联合处理后脓毒症休克逆转。
- 作者强调当代ICU几乎所有低血压患者都应接受床旁经胸超声心动图作为标准诊疗。
适用人群与场景
- 危重症患者,包括脓毒症休克人群(原文提及该人群ICU死亡率达53%)。
- 以低血压为表现、需鉴别动态左心室流出道梗阻的ICU患者。
诊断标准与关键阈值
- 动态左心室流出道梗阻通过床旁经胸超声心动图检测峰值压差诊断,病例中报告峰值压差分别为29 mmHg和36 mmHg。
处置流程与药物剂量
- 低血容量所致梗阻:液体复苏(病例1,峰值压差29 mmHg,复苏后逆转)。
- 正性肌力药所致高动力状态:镇痛/镇静(病例2),并需β受体阻滞(压差36 mmHg)。
- 脓毒症相关梗阻:去甲肾上腺素提升前负荷和后负荷,联合液体复苏与镇静(病例3)。
- 系列床旁经胸超声心动图监测确认压差下降。
红旗征与不能漏的情况
- 低血压患者出现动态左心室流出道梗阻,属危及生命且易被低估的并发症,需立即识别并处理。
研究设计与关键结果
- 病例系列:某三级中心3例典型病例。病例1(66岁男性)低血容量所致梗阻峰值压差29 mmHg,液体复苏后逆转,48小时内撤停血管加压药。
- 病例2(71岁女性)正性肌力药所致梗阻压差36 mmHg,需β受体阻滞,24小时内血流动力学稳定。
- 病例3脓毒症休克合并严重梗阻,经液体复苏、镇静和血管加压药优化联合处理,脓毒症休克逆转。
证据类型、等级与局限
- 证据类型:病例系列(3例典型病例),来自某三级中心。
- 局限:原文未报告局限性
对床旁实践的改变
- 作者强调当代ICU几乎所有低血压患者都应接受床旁经胸超声心动图作为标准诊疗,以识别包括动态左心室流出道梗阻在内的潜在病因并指导及时治疗。
- 作者认为动态左心室流出道梗阻需根据其多样病因进行及时、个体化管理,床旁经胸超声心动图是快速诊断、指导靶向干预和优化高危患者结局的关键工具。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Dynamic left ventricular outflow tract obstruction (LVOTO) is an increasingly recognized life-threatening condition in critically ill patients, with ICU mortality rates reaching 53% in septic shock populations. Bedside transthoracic echocardiography (TTE) has become indispensable for early detection due to its diagnostic sensitivity and real-time monitoring capabilities in ICU settings.
CASES: We present three prototypical cases managed at our tertiary center: (1) A 66-year-old male with volume depletion-induced LVOTO (peak gradient 29 mmHg) reversed by fluid resuscitation; (2) A 71-year-old female developing inotrope-induced obstruction (36 mmHg gradient) requiring β-blockade; and (3) A septic shock patient with severe LVOTO managed through combined fluid resuscitation, sedation, and vasopressor optimization.
MANAGEMENT: Pathophysiology-guided interventions included: fluid resuscitation for hypovolemia (Case 1), analgesia/sedation for hypercontractility (Case 2), and norepinephrine for preload and afterload augmentation in sepsis (Case 3). Serial TTE monitoring confirmed gradient reductions.
OUTCOMES: Early TTE-directed therapy achieved: (1) vasopressor weaning in 48 h (Case 1), (2) hemodynamic stabilization within 24 h (Case 2), and (3) septic shock reversal (Case 3).
CONCLUSION: LVOTO is a life-threatening yet underrecognized complication in critical care, requiring prompt and tailored management based on its diverse etiologies. Bedside TTE serves as an essential tool for rapid diagnosis, guiding targeted interventions, and optimizing outcomes in these high-risk patients. It should be stressed that almost all hypotensive patients in contemporary ICUs should receive bedside TTE as a standard of care, given its critical role in identifying underlying causes and informing timely treatment decisions.
参考来源
- Li X, Lin Y, Wang W, et al. Dynamic left ventricular outflow tract obstruction in critical illness: etiology-driven management and the role of bedside transthoracic echocardiography. Crit Care. 2025. PMID: 41316420. doi:10.1186/s13054-025-05748-2
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。